BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 10755997)

  • 21. Cysteine proteinases from distinct cellular compartments are recruited to phagocytic vesicles by Entamoeba histolytica.
    Que X; Brinen LS; Perkins P; Herdman S; Hirata K; Torian BE; Rubin H; McKerrow JH; Reed SL
    Mol Biochem Parasitol; 2002 Jan; 119(1):23-32. PubMed ID: 11755183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R; Jarillo-Luna A
    Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host-parasite relationships in amebiasis: conference report.
    Petri WA; Clark CG; Diamond LS
    J Infect Dis; 1994 Mar; 169(3):483-4. PubMed ID: 7908923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning of a virulence factor of Entamoeba histolytica. Pathogenic strains possess a unique cysteine proteinase gene.
    Reed S; Bouvier J; Pollack AS; Engel JC; Brown M; Hirata K; Que X; Eakin A; Hagblom P; Gillin F
    J Clin Invest; 1993 Apr; 91(4):1532-40. PubMed ID: 8473498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions.
    Stanley SL; Reed SL
    Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1049-54. PubMed ID: 11352795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue destruction and invasion by Entamoeba histolytica.
    Ralston KS; Petri WA
    Trends Parasitol; 2011 Jun; 27(6):254-63. PubMed ID: 21440507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phagocytosis mutant of Entamoeba histolytica is less virulent due to deficient proteinase expression and release.
    Hirata KK; Que X; Melendez-Lopez SG; Debnath A; Myers S; Herdman DS; Orozco E; Bhattacharya A; McKerrow JH; Reed SL
    Exp Parasitol; 2007 Feb; 115(2):192-9. PubMed ID: 16987516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of the redefinition of the agent of amoebiasis.
    Lucas R; Upcroft JA
    Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of pathogenic and non-pathogenic Entamoeba: has the question been answered?
    Mehlotra RK
    Indian J Gastroenterol; 1998 Apr; 17(2):58-60. PubMed ID: 9563222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice.
    Stanley SL; Zhang T; Rubin D; Li E
    Infect Immun; 1995 Apr; 63(4):1587-90. PubMed ID: 7890426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A DNA sequence corresponding to the gene encoding cysteine proteinase 5 in Entamoeba histolytica is present and positionally conserved but highly degenerated in Entamoeba dispar.
    Willhoeft U; Hamann L; Tannich E
    Infect Immun; 1999 Nov; 67(11):5925-9. PubMed ID: 10531249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress in the molecular biology of Entamoeba histolytica.
    Horstmann RD; Leippe M; Tannich E
    Trop Med Parasitol; 1992 Dec; 43(4):213-8. PubMed ID: 1338130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of cysteine proteinase 2 in Entamoeba histolytica or Entamoeba dispar increases amoeba-induced monolayer destruction in vitro but does not augment amoebic liver abscess formation in gerbils.
    Hellberg A; Nickel R; Lotter H; Tannich E; Bruchhaus I
    Cell Microbiol; 2001 Jan; 3(1):13-20. PubMed ID: 11207616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica.
    Lejeune M; Rybicka JM; Chadee K
    Future Microbiol; 2009 Feb; 4(1):105-18. PubMed ID: 19207103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity.
    Garcia-Nieto RM; Rico-Mata R; Arias-Negrete S; Avila EE
    Parasitol Int; 2008 Dec; 57(4):417-23. PubMed ID: 18571975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence.
    Martínez-Pérez Y; Nequiz-Avendaño M; García-Torres I; Gudiño-Zayas ME; López-Velázquez G; Enríquez-Flores S; Mendoza E; Saavedra E; Pérez-Tamayo R; León-Avila G; Olivos-García A
    Parasitol Res; 2020 Oct; 119(10):3491-3502. PubMed ID: 32886229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of pathogenesis in amebiasis.
    Das P; Debnath A; Muñoz ML
    Indian J Gastroenterol; 1999; 18(4):161-6. PubMed ID: 10531719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent findings on the pathogenicity of Entamoeba histolytica].
    Tannich E; Leippe M; Horstmann RD
    Immun Infekt; 1992 Oct; 20(5):146-50. PubMed ID: 1452192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Entamoeba histolytica cathepsin-like enzymes : interactions with the host gut.
    Kissoon-Singh V; Mortimer L; Chadee K
    Adv Exp Med Biol; 2011; 712():62-83. PubMed ID: 21660659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
    Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
    Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.